Pharmaceutical
AI Drug Discovery: Which Pharma Companies are Leading this Revolution?
In recent years, we’ve witnessed a rapid surge of investment towards the use of artificial intelligence (AI) in speeding up drug discovery and upping the success rates of pharmaceuticals research. Our aging population is just ... [Read]
Biotechnology
DERM Stock Doubles in a Month on Lebrikizumab’s Buzz
DERM stock investors are getting excited and for good reason too. Dermira (NASDAQ:DERM) released positive progress for a key drug candidate, lebrikizumab, back in mid-March and shares have been climbing since. Since March 15th, DERM stock ... [Read]
Editorspicks
TetraGenetics and ImmunoPrecise Extend Collaboration by Signing Multi-Target Service Agreement for the Discovery of Therapeutic Antibodies
VICTORIA, April 9, 2019 /CNW/ – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) is pleased to announce the extension of its collaboration with TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases. The alliance is focused ... [Read]
Biotechnology
ZYNE Stock Zooms Over 50% This Week, What Next for Zynerba?
ZYNE stock continued to gain momentum in Friday’s session and was recently moving up by 10.36% to $8.53 USD, extending its winning streak for the fourth straight session. Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) are up ... [Read]
Biotechnology
ACHN Stock Climbs After Achillion Pharmaceuticals’ Trial Fills Up
ACHN stock is one of the top performing biotech stocks so far in 2019. Shares of Achillion Pharmaceuticals (NASDAQ:ACHN) are up over 115% since early January amid several key clinical updates. In Wednesday’s session, Achillion ... [Read]
Editorspicks
ImmunoPrecise Antibodies Leverages Proprietary Technology and Expertise to Create Talem Therapeutics
VICTORIA, April 4, 2019 /CNW/ – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2) announces it has formed a wholly-owned, Cambridge, Massachusetts-based subsidiary, Talem Therapeutics (Talem). Talem is focused on the discovery and development of next-generation, fully-human, monoclonal therapeutic antibodies targeting neurology, immuno-oncology, gastroenterology, ... [Read]
Biotechnology
Biotech Stocks on Radar: FibroGen, Heron Therapeutics, GW, and Assembly
We’ve shortlisted four major biotech stocks with upcoming news in April related to FDA decisions. Where will the news take GW Pharmaceuticals (NASDAQ:GWPH), FibroGen (NASDAQ:FGEN), Heron Therapeutics (NASDAQ:HRTX), and Assembly Biosciences (NASDAQ:ASMB)? Biotech Stocks: GW Pharmaceuticals ... [Read]
Biotechnology
AVEO Stock Extends Rally: Up 115% in Week After Rumors Continue
AVEO stock continued to gain momentum in Tuesday’s session and was recently trading up by 13.50% to $1.26 USD, extending its winning streak for the third straight session. Shares of AVEO Pharmaceuticals (NASDAQ:AVEO), a biopharmaceutical ... [Read]
Biotechnology
AEZS Climbs: Acquisition Buzz Hypes Aeterna Zentaris Stock
Aeterna Zentaris (TSX:AEZS) (NASDAQ:AEZS) stock is having a spectacular run on the market lately with a gain of over 25% in the past two weeks. Why the climb? It likely has to do with the ... [Read]
Biotechnology
Penny Stocks to Watch: MidaTech Pharma Made Huge Gains in March
There’s a reason investors like penny stocks. Shares over $5 USD just don’t bring the same sudden explosive price jumps. For example, it’s a rare thing for a “regular” share to suddenly jump up 300% ... [Read]